KRYS Company Profile and Key Details

Q: Who are the executives of KRYS?

Ms. Gloria LinAccounting Mang.Dr. Andrew C. OrthExecutive Vice President & Chief Commercial OfficerMr. Josh SuskinDirector of HR & OperationsMs. Katherine TuminelloHR & Office Mang.Mr. David GlynnGen. Counsel, Commercial & ComplianceMr. John KarakkalVice President of North American Sales & MarketingDr. Andreas C. OrthExecutive Vice President & Chief Commercial OfficerMr. Krish S. Krishnan M.B.A., M.S.Founder, Chairman, Pres & Chief Executive OfficerMs. Suma M. KrishnanFounder, Chief Operating Officer, Pres of R&D and DirectorMr. John GarciaSenior Vice President of U.S. Bus. Sales & OperationsMs. Meg DodgeVice President of Investor Relations & Corporation CommunicationsMs. Kathryn A. RomanoExecutive Vice President & Chief Accounting OfficerMr. Ram KamineniSenior Vice President of CMC & Technical OperationsMr. Laurent GouxSenior Vice President & GM of Europe

NASDAQ : KRYS

Krystal Biotech

$305.71

9.01+3.04%

At Close 4:00 PM

69.18

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Krystal Biotech, Inc. (KRYS) stock surged +3.04%, trading at $305.71 on NASDAQ, up from the previous close of $296.70. The stock opened at $297.35, fluctuating between $292.25 and $306.10 in the recent session.

Stock Snapshot

296.7

Prev. Close

9.01B

Market Cap

292.25

Day Low

40.87

P/E Ratio

7.48

EPS (TTM)

-3.57

Cash Flow per Share

297.35

Open

29.48M

Number of Shares

306.1

Day High

79.4%

Free Float in %

27.64

Book Value

465.95K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 08, 2026	297.00	306.10	292.00	305.71	470.27K
May 07, 2026	288.99	297.48	279.74	296.70	599.57K
May 06, 2026	286.28	290.00	280.10	288.99	288.69K
May 05, 2026	291.12	303.00	283.50	284.57	412.85K
May 04, 2026	265.60	287.64	251.97	286.95	657.74K
Apr 30, 2026	260.78	262.97	257.79	262.26	181.31K
Apr 29, 2026	265.82	270.44	257.52	259.95	212.4K
Apr 28, 2026	273.87	276.95	268.68	269.27	142.58K
Apr 27, 2026	272.01	281.65	267.94	272.75	242.35K
Apr 23, 2026	276.23	278.75	266.64	268.04	160.34K
Apr 22, 2026	275.17	278.06	271.31	275.94	367.72K
Apr 21, 2026	277.47	277.47	271.62	272.66	160.92K
Apr 20, 2026	274.37	278.86	272.00	276.50	210.39K
Apr 17, 2026	268.88	276.24	267.31	274.21	327.19K
Apr 16, 2026	266.92	267.39	262.02	264.06	218.79K
Apr 14, 2026	267.86	275.75	267.86	270.00	389.16K
Apr 13, 2026	259.12	268.10	256.56	267.41	240.86K
Apr 10, 2026	258.87	259.89	255.61	259.00	162.52K
Apr 09, 2026	262.46	262.86	252.30	258.33	228.21K
Apr 08, 2026	267.42	272.12	262.27	264.22	298.37K

Contact Details

Pittsburgh, PA 15203

United States

https://www.krystalbio.com 412 586 5830

About Company

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Stock Peers

ARGX

-5.14-0.65%

argenx SE$782.17 REGN

5.79+0.82%

Regeneron Pharmaceuticals, Inc.$714.89 UTHR

-4.24-0.74%

United Therapeutics Corporation$564.94 MDGL

-24.82-4.64%

Madrigal Pharmaceuticals, Inc.$510.04 VRTX

4.82+1.13%

Vertex Pharmaceuticals Incorporated$429.82 PRAX

-3.26-0.98%

Praxis Precision Medicines, Inc.$330.02 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-0.86-0.29%

Alnylam Pharmaceuticals, Inc.$295.05 ASND

-7.48-3.04%

Ascendis Pharma A/S$238.66 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Krystal Biotech, Inc. (KRYS) stock price?

Krystal Biotech, Inc. (NASDAQ: KRYS) stock price is $305.71 in the last trading session. During the trading session, KRYS stock reached the peak price of $306.10 while $292.25 was the lowest point it dropped to. The percentage change in KRYS stock occurred in the recent session was 3.04% while the dollar amount for the price change in KRYS stock was $9.01.

KRYS's industry and sector of operation?

The NASDAQ listed KRYS is part of Biotechnology industry that operates in the broader Healthcare sector. Krystal Biotech, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KRYS?

Ms. Gloria Lin
Accounting Mang.
Dr. Andrew C. Orth
Executive Vice President & Chief Commercial Officer
Mr. Josh Suskin
Director of HR & Operations
Ms. Katherine Tuminello
HR & Office Mang.
Mr. David Glynn
Gen. Counsel, Commercial & Compliance
Mr. John Karakkal
Vice President of North American Sales & Marketing
Dr. Andreas C. Orth
Executive Vice President & Chief Commercial Officer
Mr. Krish S. Krishnan M.B.A., M.S.
Founder, Chairman, Pres & Chief Executive Officer
Ms. Suma M. Krishnan
Founder, Chief Operating Officer, Pres of R&D and Director
Mr. John Garcia
Senior Vice President of U.S. Bus. Sales & Operations
Ms. Meg Dodge
Vice President of Investor Relations & Corporation Communications
Ms. Kathryn A. Romano
Executive Vice President & Chief Accounting Officer
Mr. Ram Kamineni
Senior Vice President of CMC & Technical Operations
Mr. Laurent Goux
Senior Vice President & GM of Europe

How KRYS did perform over past 52-week?

KRYS's closing price is 148.95% higher than its 52-week low of $122.80 where as its distance from 52-week high of $306.10 is -0.13%.

How many employees does KRYS have?

Number of KRYS employees currently stands at 275.

Link for KRYS official website?

Official Website of KRYS is: https://www.krystalbio.com

How do I contact KRYS?

KRYS could be contacted at phone 412 586 5830 and can also be accessed through its website. KRYS operates from 2100 Wharton Street, Pittsburgh, PA 15203, United States.

How many shares of KRYS are traded daily?

KRYS stock volume for the day was 465.95K shares. The average number of KRYS shares traded daily for last 3 months was 298.16K.

What is the market cap of KRYS currently?

The market value of KRYS currently stands at $9.01B with its latest stock price at $305.71 and 29.48M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	275
Beta	0.51
Sales or Revenue	$50.70M
5Y Sales Change%	19.367%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	275
Beta	0.51
Sales or Revenue	$50.70M
5Y Sales Change%	19.367%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KRYS Company Profile and Key Details

Krystal Biotech

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook